Yimei Li

6.9k total citations
254 papers, 4.1k citations indexed

About

Yimei Li is a scholar working on Pediatrics, Perinatology and Child Health, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Yimei Li has authored 254 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Pediatrics, Perinatology and Child Health, 63 papers in Oncology and 62 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Yimei Li's work include Childhood Cancer Survivors' Quality of Life (66 papers), Acute Lymphoblastic Leukemia research (43 papers) and Neuroblastoma Research and Treatments (26 papers). Yimei Li is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (66 papers), Acute Lymphoblastic Leukemia research (43 papers) and Neuroblastoma Research and Treatments (26 papers). Yimei Li collaborates with scholars based in United States, China and Canada. Yimei Li's co-authors include Richard Aplenc, Brian T. Fisher, Alix E. Seif, Yuan‐Shung Huang, John M. Maris, Rochelle Bagatell, Kelly Getz, Kristina A. Cole, Mike R. Russell and Lamia P. Barakat and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Journal of Neuroscience.

In The Last Decade

Yimei Li

237 papers receiving 4.0k citations

Peers

Yimei Li
Yves Bertrand France
Riccardo Riccardi Italy
Brad H. Pollock United States
Wei‐Yann Tsai United States
Masha Kocherginsky United States
Jingxia Liu United States
Takuhiro Yamaguchi Japan
Shahrukh K. Hashmi United States
Therése Andersson Sweden
Jane L. Meza United States
Yves Bertrand France
Yimei Li
Citations per year, relative to Yimei Li Yimei Li (= 1×) peers Yves Bertrand

Countries citing papers authored by Yimei Li

Since Specialization
Citations

This map shows the geographic impact of Yimei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yimei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yimei Li more than expected).

Fields of papers citing papers by Yimei Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yimei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yimei Li. The network helps show where Yimei Li may publish in the future.

Co-authorship network of co-authors of Yimei Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yimei Li. A scholar is included among the top collaborators of Yimei Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yimei Li. Yimei Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yimei, Yang Qiao, Jordan Gauthier, et al.. (2025). A Novel R Shiny Tool TVCurveTM for Survival Analysis with Time-Varying Covariate in Oncology Clinical Studies: Overcoming Biases and Enhancing Collaboration. Transplantation and Cellular Therapy. 31(2). S23–S24.
2.
Wu, Shengjie, Yimei Li, Sue C. Kaste, et al.. (2025). Comparing Whole-Body Diffusion-weighted MRI to Conventional Imaging: Staging Pediatric Bone and Soft-Tissue Sarcomas. Radiology Imaging Cancer. 7(5). e240475–e240475.
3.
Li, Yimei, Robert M. Nelson, Rima Izem, et al.. (2024). Unlocking the Potential: A Systematic Review of Master Protocol in Pediatrics. Therapeutic Innovation & Regulatory Science. 58(4). 634–644.
4.
DiNofia, Amanda M., Yimei Li, Susan R. Rheingold, et al.. (2024). Therapies and outcomes following extramedullary relapse of pediatric and young adult ALL after CD19 CAR T-cell therapy. Blood Advances. 9(2). 354–359. 1 indexed citations
5.
6.
Leahy, Allison Barz, Jennifer L. Brogdon, Amanda M. DiNofia, et al.. (2024). Cost-Effective Manufacture and Promising Initial Efficacy of huCART19 Cells Manufactured Using the Clinimacs Prodigy Platform. Blood. 144(Supplement 1). 3470–3470. 1 indexed citations
7.
Yu, Yanan, Danfeng Ying, Shijie Xu, et al.. (2023). Graphene coated lithium foil anode enables long cycle life Li metal pouch cells. Carbon. 215. 118498–118498. 5 indexed citations
8.
Kotch, Chelsea, et al.. (2023). The Impact of Proactive Gastrostomy Tube Placement on Treatment-related Outcomes in Young Children With High-grade Central Nervous System Tumors. Journal of Pediatric Hematology/Oncology. 45(6). 333–338. 1 indexed citations
9.
Li, Yimei, Wei‐Ting Hwang, Shannon L. Maude, et al.. (2022). Statistical Considerations for Analyses of Time-To-Event Endpoints in Oncology Clinical Trials: Illustrations with CAR-T Immunotherapy Studies. Clinical Cancer Research. 28(18). 3940–3949. 8 indexed citations
10.
Batra, Vandana, Minu Samanta, Mehran Makvandi, et al.. (2022). Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma. Clinical Cancer Research. 28(18). 4146–4157. 18 indexed citations
11.
Hobbie, Wendy L., Yimei Li, Claire Carlson, et al.. (2021). Late effects in survivors of high‐risk neuroblastoma following stem cell transplant with and without total body irradiation. Pediatric Blood & Cancer. 69(3). e29537–e29537. 11 indexed citations
12.
Lau‐Min, Kelsey S., Yimei Li, Jennifer R. Eads, et al.. (2021). Adherence to and determinants of guideline‐recommended biomarker testing and targeted therapy in patients with gastroesophageal adenocarcinoma: Insights from routine practice. Cancer. 127(14). 2562–2570. 1 indexed citations
13.
Li, Yimei, Kelly Getz, Caitlin W. Elgarten, et al.. (2020). Identifying relapses and stem cell transplants in pediatric acute lymphoblastic leukemia using administrative data: Capturing national outcomes irrespective of trial enrollment. Pediatric Blood & Cancer. 68(9). e28315–e28315. 1 indexed citations
14.
Burns, Julianne E., Yimei Li, Wendy Gómez García, et al.. (2020). Assessment of the impact of inpatient infectious events in pediatric patients with newly diagnosed acute leukemia at Dr. Robert Reid Cabral Children’s Hospital, Dominican Republic. PLoS ONE. 15(12). e0243795–e0243795. 1 indexed citations
15.
Hart, Lori S., JulieAnn Rader, Pichai Raman, et al.. (2016). Preclinical Therapeutic Synergy of MEK1/2 and CDK4/6 Inhibition in Neuroblastoma. Clinical Cancer Research. 23(7). 1785–1796. 57 indexed citations
16.
Armstrong, Carol L., Michael J. Fisher, Yimei Li, et al.. (2016). Neuroplastic Response After Radiation Therapy for Pediatric Brain Tumors: A Pilot Study. International Journal of Radiation Oncology*Biology*Physics. 95(3). 991–998. 4 indexed citations
17.
Russell, Mike R., Derek A. Oldridge, Juan R. Alvarez‐Dominguez, et al.. (2015). CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus. Cancer Research. 75(15). 3155–3166. 120 indexed citations
18.
Infarinato, Nicole R., Jin H. Park, Kateryna Krytska, et al.. (2015). The ALK/ROS1 Inhibitor PF-06463922 Overcomes Primary Resistance to Crizotinib in ALK-Driven Neuroblastoma. Cancer Discovery. 6(1). 96–107. 116 indexed citations
19.
Rader, JulieAnn, Mike R. Russell, Lori S. Hart, et al.. (2013). Dual CDK4/CDK6 Inhibition Induces Cell-Cycle Arrest and Senescence in Neuroblastoma. Clinical Cancer Research. 19(22). 6173–6182. 308 indexed citations
20.
Russell, Mike R., JulieAnn Rader, Lili T. Belcastro, et al.. (2012). Combination Therapy Targeting the Chk1 and Wee1 Kinases Shows Therapeutic Efficacy in Neuroblastoma. Cancer Research. 73(2). 776–784. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yves Bertrand Breakdown of academic impact, for papers by Riccardo Riccardi Breakdown of academic impact, for papers by Brad H. Pollock Breakdown of academic impact, for papers by Wei‐Yann Tsai Breakdown of academic impact, for papers by Masha Kocherginsky Breakdown of academic impact, for papers by Jingxia Liu Breakdown of academic impact, for papers by Takuhiro Yamaguchi Breakdown of academic impact, for papers by Shahrukh K. Hashmi Breakdown of academic impact, for papers by Therése Andersson Breakdown of academic impact, for papers by Jane L. Meza
Rankless by CCL
2026